Cardiogenic shock in ACS. Part 2: Role of mechanical circulatory support

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Critical Care Medicine

Background:

• Profound postinfarction cardiogenic shock often leads to death without advanced interventions.
• Evidence for circulatory support devices in shock is primarily from clinical experience due to ethical trial limitations.
• Intra-aortic balloon pumps have not demonstrated survival benefits in established cardiogenic shock.

Purpose of the Study:

• To review contemporary circulatory support strategies for severe cardiogenic shock.
• To highlight advancements in mechanical circulatory support devices.
• To discuss the role of extracorporeal membrane oxygenation and ventricular unloading pumps.

Main Methods:

• Review of clinical experience and published series on circulatory support.
• Analysis of the efficacy and limitations of various mechanical circulatory support devices.
• Discussion of extracorporeal membrane oxygenation (ECMO) and rotary pumps.

Main Results:

• Mechanical blood pump safety and durability have improved, transforming outcomes in acute heart failure.
• Extracorporeal membrane oxygenation (ECMO) is a valuable temporary measure for resuscitation and transport but does not unload the left ventricle.
• Effective left ventricular unloading is achieved with temporary rotary or volume-displacement pumps.
• Published data suggest 50-75% of patients with profound shock can be salvaged.

Conclusions:

• Modern mechanical circulatory support, particularly rotary pumps, offers significant improvements for patients with acute heart failure and cardiogenic shock.
• While ECMO provides initial stabilization, ventricular unloading with mechanical pumps is crucial for recovery.
• Salvage rates of 50-75% are achievable through native heart recovery, transplantation, or long-term mechanical support.